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Objective: It is often said that repeating OAE hearing screening more than two or three times per ear creates statistical artifacts that unacceptably
increase false-negatives (i.e., passing babies who have permanent hearing loss). This study evaluated the accuracy of that recommendation for
screening with transient evoked otoacoustic emissions (TEOAE).
Design: The false negative rate was estimated using a 2.0 cc coupler and three human ears with moderate or worse hearing loss. Using those
results and the prevalence of hearing loss among newborns, the number of babies with hearing loss that would be missed due to repeated testing was
calculated.
Results: Only 1% of ears with moderate or worse hearing loss will be missed due to statistical probability of false-negatives resulting from repeated
testing.
Conclusions: Excessive repeated testing in a newborn hearing screening program wastes time; raises questions about accuracy of screening; and may
disturb the infant, family, or hospital staff. Repeated TEAOE testing does not cause statistical artifacts that result in a significant number of babies with
hearing loss to pass the screening test. Not repeating screening tests often enough may needlessly inflate the number of babies referred for diagnostic
testing and create financial burdens and worry for families.
Acronyms: ABR = Auditory Brainstem Response, EHDI = Early Hearing Detection and Intervention, JCIH = Joint Committee on Infant Hearing, NBHS = Newborn Hearing
Screening, OAE = Otoacoustic Emissions, TEOAE = Transient-Evoked Otoacoustic Emissions
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Introduction
Otoacoustic emissions (OAE) testing is used worldwide in
hospitals and clinics to test cochlear function of individuals
in all age groups. The most common use of OAE testing
is in hospital-based newborn hearing screening programs
as an objective measure to identify infants who require
additional diagnostic audiologic testing to confirm the
presence or absence of hearing loss. The screening test
is often performed with a hand-held unit that measures the
presence or absence of an OAE in response to an auditory
stimulus (Kemp, 1978). Screening is done by placing a
small probe in the ear canal that delivers a low-intensity
signal to the structures of the cochlea in the inner ear. If the
cochlea is functioning normally, the outer hair cells of the
cochlea respond by producing an otoacoustic emission,
sometimes described as an echo, that travels back through
the middle ear and the ear canal and is detected by the
screening unit (NCHAM, 2011). There is widespread
agreement that doing hearing screening with OAE testing is
reliable, harmless, and effective (e.g., ASHA, 2004; JCIH,
2007; Keppler, Dhooge, & Maes, 2010; White, 2014).
Currently, every state in the United States has implemented
either a mandatory or voluntary newborn hearing screening

(NBHS) program. Many of these programs use OAE
screening equipment (White, 2014) due to the safety and
ease-of-use. Every state-based Early Hearing Detection
and Intervention (EHDI) program has a coordinator who
collaborates with stakeholders in the state to implement
and support effective newborn hearing screening programs.
In 1995, the percentage of newborns screened for hearing
loss was just 3%. A decade later that number had increased
to 95% (White, 2006; White, Forsman, Eichwald, & Munoz,
2010), largely owing to the ease with which screening could
be done and the wide acceptance of reliable and objective
screening tools. The Centers for Disease Control and
Prevention (CDC; 2015) report that 98% of newborns in the
United States are currently screened for hearing loss.
Recomendations Regarding Repeating Newborn
Hearing Screening Tests
The Joint Committee on Infant Hearing (JCIH, 2007)
provides guidelines for all aspects of pediatric audiological
services, such as screening and diagnostic testing
protocols and hearing technology management. Many
hospital-based newborn hearing screening program
coordinators rely on the JCIH recommendations for
guidance in developing and managing their programs.
Commenting on how often the newborn hearing screening
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test should be repeated for a particular baby, the most
recent position statement of the JCIH (2007) makes the
following statement:
When statistical probability is used to make pass/
fail decisions, as is the case for OAE and automated
ABR [auditory brainstem response] screening
devices, the likelihood of obtaining a pass outcome
by chance alone is increased when screening is
performed repeatedly. (p. 903).
As support for this conclusion, JCIH cites articles referring
to the “false discovery rate” in other types of screening
programs and how this false discovery rate is increased by
repeated testing (Benjamini & Yekutieli, 2005; Hochberg
& Benjamini, 1990; Zhang, Chung, & Oldenburg, 1999).
The 2007 JCIH position statement does not specify what
constitutes repeated screening, nor quantify the increase
in the “chance pass rate.” However, as shown in Table 1,
many state-based EHDI programs and others have made
recommendations about the need to limit repeated testing
in newborn hearing screening programs.

Table 1. Examples of Statements from State EHDI
Programs and Others about Repeating Newborn
Hearing Screening Tests
“The initial hearing screening . . . . should consist of no more than 2
attempts using the same screening technique on each ear.”
(Washington State EHDI Program Guidelines, 2015)
For infants who fail the initial screen, hospitals should attempt to
re-screen the infant prior to discharge. Inpatient hearing screening
will consist of no more than two attempts using the same screening technique on each ear, assuming the infant is in an appropriate
state for testing and there are neither equipment problems nor environmental interference during the test. The likelihood of obtaining a
pass by chance alone is increased when screening is performed
repeatedly. (Minnesota State EHDI Program Guidelines, 2015)
… take caution to avoid over-screening newborns! Although there may
be factors that require the screen to be repeated, it is not recommended that babies be screened more than three times.” (Connecticut Department of Health, 2015)
“…excessive re-screening can increase the false negative rate (passing babies with actual hearing loss)…. Two screening sessions of no
more than three screens per ear are recommended, for a total of six
screens per ear.” (Iowa EHDI Program Guidelines, 2015)
“Do not screen patient more than three times per ear. Over screening
can result in a false negative result.” (Welch Allyn OAE Hearing
Screener Quick Reference Guide, 2015)
Screening too many times isn’t recommended and it can lead to false
results. . . . Your goal is not to pass every baby. “With multiple
screenings, babies with hearing loss may falsely pass.” (Newborn
Hearing Screening Training Curriculum, NCHAM, 2015)
Note. Emphasis added. EHDI = Early Hearing Detection and Intervention, OAE = optoacoustic emissions.

The recommendation to limit the number of OAE screening
tests performed in NBHS programs due to the potential
of passing babies who have hearing loss because of the
statistical probability of obtaining a false negative response
appears to have become accepted as best-practice.

Materials and Method
To estimate how many babies with moderate or worse
hearing loss are likely to be missed because of repeated
newborn hearing screening tests, it is necessary to
estimate the false negative rate of OAE screening (i.e.,
the probability of passing an ear with known hearing
loss). Unfortunately, none of the manufacturers of the
equipment used for newborn hearing screening provide
such information. Consequently, this study estimated the
false negative rate for a single test using the Biologic
AuDx® Pro OAE Screener. Because the false negative
rate could be different for other brands and types of
screening equipment (e.g., Biologic versus Otodynamics,
or OAE versus automated auditory brainstem response,
or transient evoked versus distortion product otoacoustic
emissions), the results reported here represent a starting
point for addressing questions about the frequency
of false-negatives attributable to statistical artifact in
hearing screening programs, but these results are
not the complete answer. We have demonstrated the
consequences of repeated newborn hearing screening
tests using TEOAEs with one of the most frequently
used OAE screeners. Making similar estimates for other
brands or types of screening instruments will require
additional data collection. The data collection described
below was approved by the Institutional Review Board at
Utah State University.
Participants
To estimate the false negative rate of TEOAE testing,
two participants with bilateral moderate sloping to
severe-profound hearing loss provided informed consent
to have repeated TEOAE tests. Audiograms for each
of three ears are shown in Figure 1. One thousand
transient evoked OAE (TEOAE) tests were obtained
from the left ear of the first participant and in both ears
of the second participant for a total of 3,000. Additionally,
1,000 TEOAEs were collected using a 2.0 cc coupler.
Equipment and Procedures
Using the Biologic AuDx® Pro OAE screener, all
screening tests were completed with the TEOAE
screening default test parameters (see Table 2).
TEOAEs were selected for this study due to their
common usage in NBHS programs and their high
sensitivity and specificity in detecting outer hair cell
dysfunction (Cunningham, 2011; Keppler et al., 2010;
Lapsley-Miller & Marshall, 2001).
Data were collected in a quiet room on each ear over
a 2-week period, averaging approximately 200 tests
per day. Within each data collection time period, the
probe was securely placed into the canal of the ear
being tested and remained in place throughout the test
session. The probe was not removed and then re-fitted
after each individual TEOAE test. Data were collected
under the supervision of a licensed audiologist.
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Figure 1. Audiograms for Ears Used to Estimate False-Negative Rate of Transient-Evoked Otoacoustic Emission
(TEOAE) Hearing Screening Tests. Different subscripts indicate different people.
Table 2. Bio-logic AuDx® TEOAE System Default Protocol

Number of frequencies for overall pass

0

Number of samples per set

3

Checkfit trials

10

Calibration trials

10

Number of successes to pass

1

Number of calibration successes to pass

1

Number of checkfit failures until refit

7

Number of calibration failures until refit

7

Checkfit/calibration artifact rejection

250

Maximum number of samples

512

Minimum percent probe stability

95

Target amplitude (dB SPL)

80

Start time (ms)

3.50

End time (ms)

Ramp time (ms)

0.98

Artifact reject (mPa)

12.0
20

Note. TEOAE = transient-evoked otoacoustic emission.
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Analysis and Results
To estimate the number of babies with moderate
or worse hearing loss that would be missed due to
repeated testing two pieces of information are needed:
a) an estimate of the false negative rate of OAE testing
due to statistical artifact; and, b) the incidence of
congenital hearing loss.
False Negative Rate of OAE Testing
The false negative rate for OAE screening is the number
of times a pass result is obtained for an ear that has
hearing loss. Of the three ears with hearing loss that
were tested 1,000 times, one ear had 999 fails, a second
had 1,000 fails, and the third had 998 fails. Testing with
the 2.0 cc coupler had similar results with 1,000 fails.
Based on these results, the false negative rate for this
piece of TEOAE screening equipment was estimated to
be 1 per 1,000. The fact that the false negative rate was
based on adult ears instead of infant ears is a limitation.
However, the authors of the study decided that it was
not practical or appropriate to repeat a screening test
1,000 times on a newborn. If the false negative rate
for newborns is substantially higher for newborns than
for adults, the results would be different. However, as
discussed below, even in the unlikely event that the false
negative rate for newborns is ten times as high as the
rate estimated for adults, it does not change the basic
conclusions of this study.

Prevalence of Congenital Hearing Loss
In the latest data available, staff at state-based EHDI
programs reported an average of 1.5 babies per 1,000
with permanent hearing loss (CDC, 2015). However,
as noted by White (2014) this number is likely a low
estimate of the number of babies with congenital hearing
loss due to high rates of loss to follow-up in many states
and inefficient newborn hearing screening programs
and/or poor documentation in some states. White (2014)
suggested that a better estimate is 3.0 per 1,000 births.
For this study, the higher number for the incidence of
congenital hearing loss was used to estimate a worst
case scenario of how many babies with hearing loss
were likely to be missed due to repeated TEOAE testing.
Analyses
In calculating the number of ears with permanent
hearing loss that are likely to be missed due to repeated
screening, we must first focus on only those ears that
have hearing loss, because it is impossible to “miss”
ears that have normal hearing. If 10,000 ears with
hearing loss were tested with the probability of an
accurate test being 0.9990 as estimated above, ten ears
with permanent hearing loss would be missed as shown
in the first row of Table 3.

Table 3. Number of Ears with Permanent Hearing Loss in a General Population Sample of 100,000 that are Missed
Due to Repeated Screening Tests if False Negative Rate is 1 per 1,000.
Based on a True False Negative Rate of 1 per 1,000
False negatives per
Probability of an ear
# of
10,000 ears with
with hearing loss
screening
hearing loss
failing the test
tests

False negatives per
10,000,000 newborns ears
in the general population

False negatives per
100,000 newborn ears in
the general population

% of “missed”
newborn ears with
hearing loss

1
2
3
4
5
10
15
20
25

30.0
60.0
89.9
119.8
149.7
298.7
446.9
594.3
741.1

0.30
0.60
0.90
1.20
1.50
2.99
4.47
5.94
7.41

0.10%
0.20%
0.30%
0.40%
0.50%
1.00%
1.49%
1.98%
2.47%

0.9990
0.9980
0.9970
0.9960
0.9950
0.9900
0.9851
0.9802
0.9753

10.0
20.0
30.0
39.9
49.9
99.6
149.0
198.1
247.0
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The incidence of a missed hearing loss if every ear is
tested once is obtained by multiplying the incidence of a
false negative in the population of ears with hearing loss
(10 per 10,000) by the incidence of hearing loss in the
general population (3 per 1,000). Thus, the incidence of
missed ears if only one screening test were done is 30
per 10,000,000. Converting this to a number that is more
realistic for state-based EHDI programs, 0.30 ears with
hearing loss would be missed for every 100,000 ears in the
general population as shown in the first row of the rightmost column in Table 3.
But what happens if the screening test is repeated multiple
times? As noted in the JCIH (2007, p. 903) position
statement, when a test is less than 100% accurate, “the
likelihood of obtaining a pass outcome by chance alone
is increased when screening is performed repeatedly.”
In this case, it was estimated that the test is only 99.9%
accurate, so there is no question that the likelihood of a
false negative will be increased—but by how much and is it
enough to be concerned?
The probability of a false negative result due to statistical
artifacts of repeated testing is estimated by multiplying
the accuracy of each test in the series and subtracting the
result from 1.0. Thus, the probability of a false negative for
two tests is:
1– (0.999 x 0.999) = 0.998.
The probability when three tests are given is:
1 – (0.999 x 0.999 x 0.999) = 0.997.
Similar calculations can be done for however many tests
are given and selected results are shown in Table 3. The
number of ears that would be missed due to statistical
artifact if every ear were tested from 2–25 times is very
small because the false negative rate of each individual test
is only 1 per 1,000 and the incidence of hearing loss among
babies is only 3 per 1,000. For example, in a population
of 50,000 babies (or 100,000 ears), we would expect 150
babies with permanent hearing loss (3 babies per 1,000 ×
50,000 babies). But, if every one of these 50,000 babies

were tested ten times in each ear, only 2.99 ears (or about
1.0% of the 300 ears with permanent hearing loss) would
be missed due to statistical artifact.
Table 4 shows the number of babies’ ears that would be
missed due to statistical artifact if there were 10 times
as many false negatives (i.e., 1 per 100 instead of 1 per
1,000). Table 4 is provided to emphasize how unlikely it
is that a mistake in estimating the false negative rate per
1,000 would change the basic conclusions of this analysis.
Calculating the number of babies that would be missed due
to statistical artifact in the birth cohort of 50,000 requires
differentiating between babies with unilateral hearing loss
and babies with bilateral hearing loss. According to the
CDC (2015), 40% of babies reported in 2013 as having
congenital hearing loss were unilateral. Thus, if there
were 300 ears with permanent hearing loss missed in the
population of 100,000 ears tested, there would be 113
babies with bilateral losses (226 ears) and 74 babies with
unilateral losses (74 ears) for a total of 187 babies and 300
ears. If 1% of these ears were missed, it would be one baby
with bilateral loss and one with unilateral loss. However, the
probability of missing both ears in a baby with bilateral loss
due to statistical artifact when one ear is tested right after
the other is 1 in 1,000,000 instead of 1 in 1,000 because
the probability of two independent events happening in
sequence is the product of the probabilities of each of
those events happening independently. Thus, the chance
of a baby with bilateral hearing loss being missed due to
statistical artifact approaches zero because one or the
other of the ears would fail the testing and both ears would
be identified during follow-up diagnostic testing. Therefore,
the only baby missed would be the one with unilateral loss.
To summarize, in a birth cohort of 50,000 babies, there
would be 150 babies with congenital hearing loss, and 1
baby with unilateral loss (0.67%) would be missed due to
the statistical artifact of repeated testing.

Table 4. Number of Ears with Permanent Hearing Loss in a General Population Sample of 100,000 that are Missed
Due to Repeated Screening Tests if False Negative Rate is 1 per 100.
Based on a True False Negative Rate of 1 per 100
False negatives per
Probability of an ear
# of
10,000 ears with
with hearing loss
screening
hearing loss
failing a test
tests

False negatives per
10,000,000 newborns ears
in the general population

False negatives per
100,000 newborn ears in
the general population

% of “missed”
newborn ears with
hearing loss

1
2
3
4
5
10
15
20
25

300.0
597.0
626.4
655.8
685.1
831.4
977.0
1121.8
1265.9

3.00
5.97
6.26
6.56
6.85
8.31
9.77
11.22
12.66

1.00%
1.99%
2.09%
2.19%
2.28%
2.77%
3.26%
3.74%
4.22%

0.9900
0.9801
0.9791
0.9781
0.9772
0.9723
0.9674
0.9626
0.9578

100.0
199.0
208.8
218.6
228.4
277.1
325.7
373.9
422.0
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Discussion
The positive impact of effective NBHS programs on the
linguistic and academic development of children who
are deaf or hard of hearing has been well documented
(Kennedy et al., 2006; Marge & Marge, 2005; Moeller,
2000; Yoshinaga-Itano, Sedey, Coutler, & Mehl, 1998).
Although programs should seek to improve screening
methods and minimize false OAE test results, the goal of
a screening program should not be to pass every baby
tested. Instead, programs should identify and implement
effective screening protocols and procedures with welltrained personnel so that the results of screening tests are
reliable and accurate.
Even though it is estimated that less than 1% of the babies
with moderate or worse permanent hearing would be
missed due to statistical artifacts, there are a number of
other potentially adverse effects if OAE screening tests
are repeated too often in a newborn hearing screening
program. For example, frequent repetition of OAE
screening may:
1. Be an inefficient use of resources because staff are often
repeating tests that are unlikely to have different results.
2. Decrease the confidence that health care providers
(e.g., nurses, physicians, etc.) and parents have about
the efficacy of the NBHS program or the testing process
because tests are being repeated so frequently.
Conversely, not repeating the OAE test enough times to
get an accurate result can result in an excessive number of
false positive results where infants with normal hearing are
discharged from the hospital with a failed OAE test result.
For example, it is well known that cerumen or other debris
in the ear canal of newborns can cause a fail screening
result for babies with normal hearing (White, 2014). Such
debris often clears after a few hours and a baby with
normal hearing who has failed the initial screening will often
pass a subsequent screening. Similarly, a baby with normal
hearing who is very agitated during a screening test may
fail because the probe is not positioned correctly or there is
too much noise in the screening environment. Retesting at
a later time will often result in an accurate pass result.
If too many babies with normal hearing have failed the
screening test when they leave the hospital, overall
screening costs increase due to a large number of babies
who must be followed and brought back for additional
testing. Doing follow-up testing with an unnecessarily high
number of infants not only increases costs, but it may
cause parents undue alarm and anxiety, undermining
confidence in the screening program among all
stakeholders (Clemens, Davis, & Bailey, 2000).
The ramifications of over-testing or under-testing illustrate
the importance of effective and appropriate screening
protocols (Wada, Kubo, Aiba, & Yamane, 2004). In
addressing potential program improvements to increase
the accuracy of hearing screening procedures, program
administrators may benefit from re-evaluating their

procedures, including clarifications for when to test, how
to test, and providing a clear protocol for what constitutes
a testing attempt. For example, attempting to test when
the baby is agitated or when the test environment is
excessively noisy will often result in a failed screening
result even if the baby has normal hearing. Debris in the
test probe, excessive cerumen in the infant’s ear canal, or
the probe tip blocked against the canal wall also should
be identified so that effective adjustments can be made
prior to attempting the OAE test. Well-trained screeners
can readily identify adverse test conditions, ensure proper
probe fit, and proceed with testing only when conditions are
conducive to obtaining an accurate test result.
There are a number of resources that can guide NBHS
program administrators to evaluate their current program
procedures and identify potential areas of improvement.
For example, NCHAM offers free online training modules
for newborn hearing screening programs (http://www.
infanthearing.org/nhstc/). Even those who believe their
screening programs are highly effective may benefit from
regularly evaluating program processes to ensure the
screening follows best-practice recommendations.
Conclusions
It is appropriate for administrators of newborn hearing
screening programs to be concerned about how often OAE
screening should be repeated—but not because repeated
screening prior to discharge will result in a high number of
false negative results due to statistical artifacts. As shown
in this article, very few babies with permanent hearing loss
are likely to pass a newborn hearing screen test because
the test was repeated multiple times. Even if a TEOAE
screening test were repeated ten times for every baby,
fewer than 1% of those with permanent hearing loss would
pass because of repeated testing.
It should be noted that once a baby has failed the newborn
hearing screening test, diagnostic assessment to determine
the baby’s hearing status should be done as soon as
possible. The results of this study should not be used to
justify repeated OAE screening after the baby is discharged
from the hospital as a prerequisite for doing the diagnostic
evaluation. Such a practice has nothing to do with false
negatives as a result of statistical artifacts of repeated
testing and will only delay diagnosis and commencement of
appropriate early intervention.
It is important for administrators of NBHS programs
to be thoughtful about how often newborn hearing
screening tests are repeated and to train their screeners
accordingly. Not repeating the test often enough will lead to
inappropriately high numbers of babies with normal hearing
who fail a screen. This will lead to higher costs for followup screening and diagnostic testing. Repeating screening
tests too often is also an inefficient use of staff time and
may undermine the credibility of the program.
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Newborn hearing screening programs should have welltrained screeners who recognize when to attempt testing
and when to repeat OAE testing to obtain an accurate
test result rather than focusing on the number of tests
performed. To do otherwise can undermine the success
of the screening program by wasting time, disturbing the
baby, and upsetting parents and health care providers.
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